Best OG - Search Results

1

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.

Huang PY, Best OG, Almazi JG, Belov L, Davis ZA, Majid A, Dyer MJ, Pascovici D, Mulligan SP, Christopherson RI. Huang PY, et al. Among authors: best og. Leuk Lymphoma. 2014 Sep;55(9):2085-92. doi: 10.3109/10428194.2013.867486. Epub 2014 Jan 24. Leuk Lymphoma. 2014. PMID: 24289109

2

Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies.

Mynott RL, Habib A, Best OG, Wallington-Gates CT. Mynott RL, et al. Among authors: best og. Int J Mol Sci. 2023 Apr 21;24(8):7661. doi: 10.3390/ijms24087661. Int J Mol Sci. 2023. PMID: 37108836 Free PMC article. Review.

3

ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.

Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG. Best OG, et al. Cytometry B Clin Cytom. 2006 Jul 15;70(4):235-41. doi: 10.1002/cyto.b.20121. Cytometry B Clin Cytom. 2006. PMID: 16906573 Free article.

4

A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.

Best OG, Gardiner AC, Majid A, Walewska R, Austen B, Skowronska A, Ibbotson R, Stankovic T, Dyer MJ, Oscier DG. Best OG, et al. Leukemia. 2008 Jul;22(7):1456-9. doi: 10.1038/sj.leu.2405092. Epub 2008 Jan 17. Leukemia. 2008. PMID: 18200038 No abstract available.

5

A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.

Best OG, Gardiner AC, Davis ZA, Tracy I, Ibbotson RE, Majid A, Dyer MJ, Oscier DG. Best OG, et al. Leukemia. 2009 Jan;23(1):212-4. doi: 10.1038/leu.2008.260. Epub 2008 Sep 25. Leukemia. 2009. PMID: 18818700 No abstract available.

6

The precursor of chronic lymphocytic leukemia.

Mulligan CS, Best OG, Mulligan SP; Chronic Lymphocytic Leukaemia Australian Research Consortium. Mulligan CS, et al. Among authors: best og. N Engl J Med. 2009 Jun 11;360(24):2575; author reply 2575-6. doi: 10.1056/NEJMc090559. N Engl J Med. 2009. PMID: 19516039 No abstract available.

7

The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway.

Best OG, Singh N, Forsyth C, Mulligan SP. Best OG, et al. Br J Haematol. 2010 Oct;151(2):185-8. doi: 10.1111/j.1365-2141.2010.08348.x. Br J Haematol. 2010. PMID: 20738310 Free article.

8

Surface profiles for subclassification of chronic lymphocytic leukemia.

Huang PY, Best OG, Belov L, Mulligan SP, Christopherson RI. Huang PY, et al. Among authors: best og. Leuk Lymphoma. 2012 Jun;53(6):1046-56. doi: 10.3109/10428194.2011.631370. Epub 2012 Apr 3. Leuk Lymphoma. 2012. PMID: 22023531 Review.

9

The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.

Best OG, Che Y, Singh N, Forsyth C, Christopherson RI, Mulligan SP. Best OG, et al. Leuk Lymphoma. 2012 Jul;53(7):1367-75. doi: 10.3109/10428194.2011.647310. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22149137

10

Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53.

Almazi JG, Mactier S, Best OG, Crossett B, Mulligan SP, Christopherson RI. Almazi JG, et al. Among authors: best og. Proteomics Clin Appl. 2012 Jun;6(5-6):279-90. doi: 10.1002/prca.201200003. Proteomics Clin Appl. 2012. PMID: 22641291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters